Japan · Investor

Nomura

Last cheque observed Oct 2026; 22 cheques on record.

Hedge fundDeploying nowLast fund $8.9M, Jun 2014

Series CSeries BVentureBiopharmaEnterprise SoftwareHealth Care

Deploying now
100%of best year2cheques in 12 months, 22 on record
Since the last cheque30days00hrs00min00sec
Median round$120MRounds led0 of 22Sole investor3 roundsExits2 from the portfolioMostly inUnited States, 65%
Pitch Nomura

Nomura highlights

  1. 01

    2 cheques in the last 12 months

  2. 02

    Mostly Series C and Series B: 58% of its rounds

  3. 03

    Sole investor in 3 rounds, median $16M

  4. 04

    2 exits from the portfolio

What they do

Type
Hedge fund (from a list, unverified)
Cheque size
Not stated
Sectors
BiopharmaEnterprise SoftwareHealth Care
Based in
Tokyo, Japan
Cold pitches
Not stated

The record

Every round we can evidence, newest first22 appearances

  1. 2026

    1 round

  2. Oct
    CapitolisSeries E · US · AlleyWatch$120MWith 11 others
  3. 2025

    1 round

  4. Dec
    PlataDebt · LatamList$500MWith 3 others
  5. 2024

    2 rounds

  6. Oct
    Cornerstone FinancingDebt · US · Firms' own news pages$285MWith 1 other
  7. Oct
    ExcelCreditLatamList$50MSole investor
  8. 2019

    1 round

  9. Jan
    CinnamonSeries B · JP · Thebridge$14MWith 5 others
  10. 2014

    1 round

  11. Oct
    SymphonyUS$66MWith 15 others
  12. 2013

    1 round

  13. Sept
    Zosano PharmaDebt · US$3.0MWith 2 others
  14. 2009

    2 rounds

  15. Aug
    Zosano PharmaSeries B · US · onbiovc.com$30MWith 3 others
  16. Jun
    Chroma TherapeuticsVenture · GB$25MWith 5 others
  17. 2008

    4 rounds

  18. Nov
    OncoMed PharmaceuticalsSeries B · US · biospace.com$154MWith 8 others
  19. Sept
    Moser Baer SolarSeries B · IN · vccircle.com$93MWith 4 others
  20. Aug
    Real Image Media TechnologiesVenture · IN · contentsutra.com$16MSole investor
  21. Feb
    SpeedshapeVenture · US · paidcontent.org$5.0MSole investor
  22. 2007

    4 rounds

  23. Nov
    Zosano PharmaSeries A · US · zosanopharma.com$90MWith 3 others
  24. Sept
    EcrioSeries C · US · venturebeat.com$24MWith 6 others
  25. May
    Gemini Mobile TechnologiesVenture · US · venturebeat.com$5.0MWith 3 others
  26. Mar
    PhenomixSeries C · US · phenomixcorp.com$55MWith 10 others
  27. 2006

    2 rounds

  28. Sept
    OperaxSeries C · SE · lightreading.com$15MWith 2 others
  29. Apr
    Chroma TherapeuticsSeries C · GB · chromatherapeutics.com$53MWith 4 others
  30. 2005

    2 rounds

  31. Jun
    Meriton NetworksSeries C · CA · meriton.com$54MWith 8 others
  32. Jan
    RevivioSeries C · US · flagshipventures.com$25MWith 6 others
  33. 2001

    1 round

  34. Jan
    ZoologicSeries B · US$8.0MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration12 named

EJEugene James ChiulliChief Financial Officer & Managing DirectoriForm ADV
FRFaron Ross WebbChief Legal Officer, General Counsel, Secretary & Managing DirectoriForm ADV
GJGregory James DumarkChief Compliance Officer and Managing DirectoriForm ADV
IGIan GoodallDirectoriFiling they signed
JCJames Christopher GiancarloBoard of DirectorsiForm ADV
LSLaura Simone UngerBoard of DirectorsiForm ADV
SKSatoshi KawamuraCEO, President, Senior Managing Director & Board of DirectorsiForm ADV
SNSteven Nicholas AloupisCo-Chief Executive Officer, Board of Directors & Managing DirectoriForm ADV
TWTim WoolaverDirectoriFiling they signed
VAVincent Anthony PrimianoCo-Chief Executive Officer & Managing DirectoriForm ADV
WFWilliam Francis Jr HughesChief Operations Officer & Managing DirectoriForm ADV
YIYutaka ItabashiDirectoriFiling they signed

We also hold 35 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

5+funds on filenumbered funds in its name
Registeredinvestment adviserfull reporting to the SEC
Legal name
Nomura Securities International, Inc.
SEC number
CRD 4297

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

OncoMed PharmaceuticalsListed$82MJul 2013
Meriton NetworksBought by Xtera CommunicationsUndisclosedMay 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

Lehman Brothers$225MSept 2008
InstinetUndisclosedNov 2006

Who they invest alongside

The investors most often in the same rounds as Nomura. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Nomura put money into.

Quick answers about Nomura

What does Nomura invest in?

Nomura invests most often at Series C and Series B (58% of the rounds on record), in sectors such as Biopharma, Enterprise Software and Health Care.

How active is Nomura?

22 investments on record, 2 of them in the last 12 months. The most recent was in Oct 2026.

What has Nomura invested in recently?

Its most recent investments on record: Capitolis (Series E, Oct 2026), Plata (Debt, Dec 2025) and Cornerstone Financing (Debt, Oct 2024).

How big are Nomura's cheques?

The median round it joins is $120M.

Does Nomura lead rounds?

Rarely, if at all: none of its 22 investments on record names it as the lead.

Where does Nomura invest?

Most of the companies it backs are in the United States (65%), the United Kingdom (10%) and India (10%).

Is Nomura investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

Who does Nomura invest alongside?

Most often New Enterprise Associates (3 rounds together), Abingworth (2 rounds together) and Aplix (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it